The DOI matches its Crossref record.
Tachyphylaxis in Unipolar Major Depressive Disorder
Abstract
BACKGROUND: Major depressive disorder is usually a recurring illness, and maintenance treatment is used to forestall or prevent recurrent episodes of depression. This study describes recurrence of major depression despite maintenance pharmacotherapy, termed tachyphylaxis. METHOD: The study sample consisted of 103 subjects who participated in the NIMH Collaborative Depression Study, a multicenter longitudinal observational study of the mood disorders. Subjects diagnosed with unipolar major depressive disorder according to Research Diagnostic Criteria were enrolled from 1978-1981 and prospectively followed for up to 20 years. As an observational study, treatment was recorded but not controlled by anyone connected with the study. Subjects were selected for the present study if at some point during follow-up they received antidepressant medication for treatment of an episode of major depressive disorder, recovered from this episode, and subsequently received maintenance pharmacotherapy. Some subjects were successfully treated for multiple episodes of major depressive disorder and then received maintenance medication after each of these episodes, resulting in multiple maintenance treatment intervals. Data were collected using the Longitudinal Interval Follow-Up Evaluation, and mixed-effects logistic regression was used to test the association of sociodemographic and clinical variables with tachyphylaxis. RESULTS: For the 103 subjects, there were 171 maintenance treatment intervals in which a subject received maintenance pharmacotherapy after having recovered from an episode of major depressive disorder. The median duration of maintenance treatment was 20 weeks. Tachyphylaxis occurred during 43 (25%) of these 171 maintenance treatment intervals. The subtype of melancholic (endogenous) major depressive disorder significantly elevated the risk of tachyphylaxis during the subsequent maintenance treatment interval. CONCLUSIONS: Despite the use of maintenance pharmacotherapy, major depression recurs in a considerable number of patients. Improved prophylaxis for these patients requires other treatment strategies based upon a greater understanding of recurrence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large observational study,23 failure to respond to the same medication that was used in a previous episode was found to occur in a quarter of cases.”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [23]
In the citing paper
“In patients who respond to the same AD that was used in the previous episode, a loss of therapeutic effect may then ensue.”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [23]
In the citing paper
“Similar rates were documented by the National Institute of Mental Health Collaborative Depression Study that reported the development of tolerance in up to 25% (n=43 out of 171 subsequent episodes) among 103 patients with MDD exposed to antidepressants over a 20-year follow-up period [21].”
Citations
Cites
Still being checked.
Cited by
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,510
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Kellner, C. H., Knapp, R. G., Petrides, G., Rummans, T. A., Husain, M. M., Rasmussen, K., Mueller, M., Bernstein, H. J., O’Connor, K., Smith, G., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1337 · Cited by 471
Segal, Z. V., Bieling, P., Young, T., MacQueen, G., Cooke, R., Martin, L., Bloch, R., & Levitan, R. D. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.168 · Cited by 429
“(%) 11 (39) 9 (35) 8 (27) History of substance abuse/dependence, No.”
The mechanisms of tolerance in antidepressant action
Fava, G. A., & Offidani, E. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.026 · Cited by 158
Hoffer, M. E., Balaban, C. D., Gottshall, K. R., Balough, B. J., Maddox, M. R., & Penta, J. R. (2010) · Otology & Neurotology · doi:10.1097/mao.0b013e3181c993c3 · Cited by 148
Rational Use of Antidepressant Drugs
Fava, G. A. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000362803 · Cited by 95
Fava, G. A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320970325 · Cited by 84
Combined biological tests for suicide prediction
Coryell, W. H., & Schlesser, M. A. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.01.021 · Cited by 91
Self-citationFornaro, M., Anastasia, A., Novello, S., Fusco, A., Pariano, R., De Berardis, D., Solmi, M., Veronese, N., Stubbs, B., Vieta, E., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.025 · Cited by 80
Tardive dysphoria: The role of long term antidepressant use in-inducing chronic depression
El‐Mallakh, R. S., Gao, Y., & Roberts, R. J. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.01.020 · Cited by 81
A systematic review of long-term studies of drug treated and non-drug treated depression
Hughes, S., & Cohen, D. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.027 · Cited by 71
Clinical Implications of Genetic Variation in the Serotonin Transporter Promoter Region: A Review
Luddington, N. S., Mandadapu, A., Husk, M., & El‐Mallakh, R. S. (2009) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.08r00656 · Cited by 69
Tachyphylaxis in major depressive disorder: A review of the current state of research
Kinrys, G., Gold, A. K., Pisano, V. D., Freeman, M. P., Papakostas, G. I., Mischoulon, D., Nierenberg, A. A., & Fava, M. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.357 · Cited by 45
Seemüller, F., Meier, S., Obermeier, M., Musil, R., Bauer, M., Adli, M., Kronmüller, K., Holsboer, F., Brieger, P., Laux, G., et al. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0495-7 · Cited by 45
Amsterdam, J. D., Williams, D., Michelson, D., Adler, L. A., Dunner, D. L., Nierenberg, A. A., Reimherr, F. W., & Schatzberg, A. F. (2009) · Neuropsychobiology · doi:10.1159/000226611 · Cited by 39
Treatment of recurrent depression
Fava, G. A., Park, S. K., & Sonino, N. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.11.1735 · Cited by 38
Does major depressive disorder change with age?
Coryell, W. H., Solomon, D., León, A. M., Fiedorowicz, J. G., Schettler, P. J., Judd, L. L., & Keller, M. (2009) · Psychological Medicine · doi:10.1017/s0033291709005364 · Cited by 31
Self-citationZajecka, J., D, M. F. M., Shelton, R. C., Barrentine, L. W., Young, P., & Papakostas, G. I. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10181 · Cited by 30
Peterson, T. J., Feldman, G. C., Harley, R. M., Fresco, D. M., Graves, L., Holmes, A. J., Bogdan, R., Papakostas, G. I., Bohn, L., Lury, R. A., et al. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.1.145 · Cited by 31
Thase, M. E., Gelenberg, A. J., Kornstein, S. G., Kocsis, J. H., Trivedi, M. H., Ninan, P. T., Li, T., Pedersen, R., & Keller, M. B. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.07.009 · Cited by 27
Self-citationAmsterdam, J. D., & Justine Shults, A. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.07.007 · Cited by 27
Selective Serotonin Reuptake Inhibitors: How Long Is Long Enough?
Thom, R. P., Alexander, J. L., Baron, D. A., Garakani, A., Gross, L. S., Pine, J. H., Radhakrishnan, R., Slaby, A. E., & Sumner, C. R. (2021) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000578 · Cited by 21
Chronic Depression in Bipolar Disorder
El‐Mallakh, R. S., & Karippot, A. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.8.1337 · Cited by 22
Citrome, L., & Volavka, J. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0818c · Cited by 23
Tachyphylaxis/ tolerance to antidepressive medications: a review.
Katz, G. (2011) · PubMed · Cited by 23
Amsterdam, J. D., Lorenzo‐Luaces, L., & DeRubeis, R. J. (2016) · Bipolar Disorders · doi:10.1111/bdi.12442 · Cited by 19
Hunter, A. M., Cook, I. A., & Leuchter, A. F. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.02.005 · Cited by 16
The Rothschild scale for antidepressant tachyphylaxis: reliability and validity
Rothschild, A. J. (2008) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2008.03.002 · Cited by 15
“episode despite continued treatment with a previously effective antidepressant [3,12].”
BackgroundMethodKornstein, S. G. (2006) · CNS Spectrums · doi:10.1017/s1092852900015236 · Cited by 16
Antidepressant-Induced Tardive Dysphoria
El-Mallakh, R. S., Gao, Y., Briscoe, B. T., & Roberts, R. J. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000316799 · Cited by 13
Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder
(2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0420 · Cited by 14
Katz, G. (2011) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2011.02231.x · Cited by 12
Possible Bipolar Nature of Irritability in Major Depressive Disorder
Benazzi, F. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0818a · Cited by 10
Coplan, J. D., Singh, D., Gopinath, S., Mathew, S. J., & Bulbena, A. (2015) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.14060132 · Cited by 11
Hunter, A. M., Cook, I. A., Abrams, M., & Leuchter, A. F. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.09.016 · Cited by 9
Tratamento homeopático da depressão: relato de série de casos
Adler, U. C., de Paiva, N. M., César, A. D. T., Adler, M. S., Molina, A., & Calil, H. M. (2008) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832008000200005 · Cited by 8
Will a New Genotyping Test Help the Clinician Predict Response to Antidepressant Drugs?
Parker, G. B., Rowe, M., Mehta, F., & Kumar, S. (2010) · Australasian Psychiatry · doi:10.3109/10398562.2010.498516 · Cited by 7
Tardive dysphoria: antidepressant-induced chronic depression
El‐Mallakh, R. S., Roberts, R. J., Swann, A. C., Rutherford, P. R., & Surja, A. (2011) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700011976 · Cited by 6
Cavalcanti, S., Lopez, O. A., Kung, S., Voort, J. L. V., Somers, K. J., Frye, M. A., & Singh, B. (2024) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001839 · Cited by 5
It Looks Like "Bradyphylaxis" to Me
Jefferson, J. W. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0818f · Cited by 5
Antipsychotic-Induced Sexual Dysfunction and the Strength of the Evidence
Rico‐Villademoros, F., & Calandre, E. P. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0818d · Cited by 5
Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries
Tegin, C., Tegin, G., & El‐Mallakh, R. S. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4559 · Cited by 4
Tachyphylaxis to the Sedative Action of Mirtazapine
Papazisis, G., Siafis, S., & Tzachanis, D. (2018) · American Journal of Case Reports · doi:10.12659/ajcr.908412 · Cited by 3
Use of Decision Support Tools for Treatment Algorithms
Trivedi, M. H. (2007) · CNS Spectrums · doi:10.1017/s1092852900003746 · Cited by 2
Können Antidepressiva den langfristigen Verlauf depressiver Erkrankungen negativ verändern?
Gründer, G., Mertens, L. J., Spangemacher, M., & Schmitz, C. N. (2025) · Der Nervenarzt · doi:10.1007/s00115-025-01801-1 · Cited by 1
Autonomous and motor behaviors
Crusio, W. E., Sluyter, F., Gerlai, R. T., & Pietropaolo, S. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139541022.011 · Cited by 1
Laux, G. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_67 · Cited by 3
Sadock, E. (2014) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/r9ct-jz30 · Cited by 1
Gönül, A. S. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.068 · Cited by 1
Reply to Antipsychotic-Induces Sexual Disfunction and the Strength of the Evidence
Olfson, M., Uttaro, T., Carson, W. H., & Tafesse, E. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0818e · Cited by 1
Reply to It looks like "Bradyphylaxis" to Me
Solomon, D. A. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0818g · Cited by 1
Self-citationReply to Possible Bipolar Nature of Irritability in Major Depressive Disorder
Perlis, R. H., D, M. F. M., & Rush, A. J. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0818b
Melancholia as a Useful Subtype of Major Depression
Solomon, D. A. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09l05070
Self-citationYoung, C. (2009) · KU ScholarWorks (The University of Kansas) · Cited by 2
The Effect of Varying Levels of Depressive Symptoms on Mindfulness Acquisition: An Exploratory Study
Scheller, V. K. (2013) · KU ScholarWorks (The University of Kansas)
How Mental Health Is Shortchanged by Lack of Reimbursement for Vagus Nerve Stimulation
Meyer, J. P., Noronha, A. M., & Brozak, S. (2015) · Brain stimulation · doi:10.1016/j.brs.2015.12.002
An antibiogram data model and implementation schema
Ross, D. B. (2012) · doi:10.6083/m4td9vbn
Gershenfeld, H. K. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139541022.020 · Cited by 1
Heterogeneity in Bipolar II Disorder Treatments: A Literature Review
Tavares, D. F., Moreno, D. H., & Moreno, R. A. (2018) · Brain Disorders & Therapy · doi:10.4172/2168-975x.1000250
McLaughlin, P., & Cleare, A. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623465.009
Holtzheimer, P. E. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717960210.793463237
Laux, G. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_67-1 · Cited by 1
Laux, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_55
Laux, G. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_55
Treatment of depression after acute phase of the disorder
Knežević, V. (2022) · Galenika Medical Journal · doi:10.5937/galmed2203029k
Safe Deprescribing of Antidepressants
(2024) · Wiley eBooks · doi:10.1002/9781394291052.mdg002
Gründer, G. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21199-7.00002-7
Les manifestations cliniques associées à la toxicité comportementale
Fava, G. A., & Peretti, C.-S. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-77932-9.00003-0
Metadata
- Authors
- Solomon, D. A., Leon, A. C., Mueller, T. I., Coryell, W., Teres, J. J., Posternak, M. A., Judd, L. L., Endicott, J., & Keller, M. B.
- Affiliations
- Brown University (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2005-03-15
- Volume
- 66
- Issue
- 03
- Pages
- 283-290
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1973795976
- Cited by
- 71
- References
- 0
- Citations by year
- 2025: 2 · 2024: 4 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 1 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 3
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R01MH025478, 2R10 MH25478-29A2)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- tachyphylaxis, major depressive disorder, depression recurrence, maintenance pharmacotherapy, antidepressant prophylaxis, endogenous depression
- MeSH terms
- Adult, Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Depressive Disorder, Drug Therapy, Combination, Female, Humans, Longitudinal Studies, Male, Terminology as Topic, Prospective Studies, Psychiatric Status Rating Scales, Research Design, Tachyphylaxis, Antipsychotic Agents, Survival Analysis, Treatment Outcome, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.